glp-1 advertising crackdown news FDA Issues Warnings Against Illegal Marketing Ozempic, weight-loss drugs target body

2022 Jun 4;387(3):20516

Mounjaro is a weight loss medication developed by the pharmaceutical company Eli Lilly

By 2013 five such drugs had been approved for the US market

What Aetna Members Should Do If you are an Aetna member considering Ozempic or other GLP-1 medications: Review your formulary and prescription drug coverage

With appetites suppressed and portion sizes reduced, every bite needs to contribute towards maintaining muscle mass, contributing fiber, delivering essential nutrients and supporting overall wellness

Most of these studies assessed intake using ad libitum test meals rather than 24-h dietary recalls, a methodological approach that offers the advantage of capturing voluntary eating behavior under controlled conditions but may underestimate total daily energy intake and limit extrapolation to real-world dietary patterns